Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness
May 07, 2021, 03:42 PM
Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.
You can visit our support center if you're having problems.